The Pandemic Didn't Stop Venture Capital From Flowing Into Houston's Life Sciences Sector This Year
Venture capitalists continued to invest in Houston's life sciences sector this year, despite the pandemic.
Venture capitalists continued to invest in Houston's life sciences sector this year, despite the pandemic.
Whitman-Walker Health Going the Extra Mile reception at Long View Gallery, with co-chairs Wiley Rein's Peter Shields and Johnson & Johnson's Maggie FitzPatrick
Industry experts gathered at Bisnow's Houston Healthcare even to discuss why the sector has been so strong despite Houston's perceived downturn.
The Trump administration is pushing to bring medical supply chains home.
Dealing with vacancies and expiring leases, Chesterbrook and Glenhardie corporate centers are up for sale for less than they traded for before the recession.
Thor Equities and Wafra sold the HQ of a $3.4B biotech company this week.
Facebook is reportedly subleasing 267K SF from bluebird bio in Kendall Square, a major commitment to office amid a sluggish Boston market.
Read about this week's top commercial real estate deals, funding, people moves and more, in Philadelphia.
The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to produce drugs entirely in the U.S.
With more production shifting domestically, PCL Construction is helping to meet U.S. biomanufacturing needs with its manufacturing center of excellence.
We're not asking for your money. This is not a step towards a paywall. Our news is free and we intend to keep it that way.